- Home
- ACRV vs OPFI Comparison
ACRV vs OPFI Comparison
Compare ACRV & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- OPFI
- Stock Information
- Founded
- ACRV 2018
- OPFI 2009
- Country
- ACRV United States
- OPFI United States
- Employees
- ACRV N/A
- OPFI N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- OPFI Finance: Consumer Services
- Sector
- ACRV Health Care
- OPFI Finance
- Exchange
- ACRV Nasdaq
- OPFI Nasdaq
- Market Cap
- ACRV 170.3M
- OPFI 174.4M
- IPO Year
- ACRV 2022
- OPFI N/A
- Fundamental
- Price
- ACRV $5.65
- OPFI $11.92
- Analyst Decision
- ACRV Strong Buy
- OPFI Buy
- Analyst Count
- ACRV 5
- OPFI 2
- Target Price
- ACRV $22.40
- OPFI $7.50
- AVG Volume (30 Days)
- ACRV 50.9K
- OPFI 1.8M
- Earning Date
- ACRV 11-13-2024
- OPFI 03-06-2025
- Dividend Yield
- ACRV N/A
- OPFI N/A
- EPS Growth
- ACRV N/A
- OPFI 775.86
- EPS
- ACRV N/A
- OPFI 0.38
- Revenue
- ACRV N/A
- OPFI $260,661,000.00
- Revenue This Year
- ACRV N/A
- OPFI N/A
- Revenue Next Year
- ACRV N/A
- OPFI $6.51
- P/E Ratio
- ACRV N/A
- OPFI $31.53
- Revenue Growth
- ACRV N/A
- OPFI 23.85
- 52 Week Low
- ACRV $3.19
- OPFI $2.35
- 52 Week High
- ACRV $11.90
- OPFI $12.24
- Technical
- Relative Strength Index (RSI)
- ACRV 41.71
- OPFI 72.61
- Support Level
- ACRV $5.36
- OPFI $10.66
- Resistance Level
- ACRV $6.00
- OPFI $8.73
- Average True Range (ATR)
- ACRV 0.52
- OPFI 0.95
- MACD
- ACRV -0.01
- OPFI 0.37
- Stochastic Oscillator
- ACRV 17.74
- OPFI 93.93
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.